| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |